Director, Drug Substance and Early Development
Abata TherapeuticsFull Time
Senior (5 to 8 years)
Heidelberg, Baden-Württemberg, Germany
Key technologies and capabilities for this role
Common questions about this position
A successfully completed training as BTA/CTA/PTA or a completed natural science degree is required, along with solid knowledge in microbial cultivation of bacteria and yeasts, handling of fermentation systems, and relevant analytical methods.
The position requires flexibility in working hours and readiness for shift work from Monday to Friday between 6:00 AM and 10:00 PM.
Benefits include a modern time tracking system with flexitime, regular company events, annual salary review, meal allowance via Lunch-It, JobRad program participation, employee parking, public transport subsidy, asset-effective benefits, company pension plan, training opportunities, and free coffee, tea, water, soft drinks, and fruit.
You work with a team on exciting and challenging topics in a state-of-the-art, innovative, and creative environment, with intensive on-the-job training by knowledgeable colleagues and regular company events.
Strong candidates have completed BTA/CTA/PTA training or a science degree, proven experience in microbial cultivation, high-density fermentation, molecular biology, analytical methods like SDS-PAGE and Western Blot, plus team skills, responsibility, quality awareness, good English, and shift work flexibility.
Contract development and manufacturing for biopharmaceuticals
AGC Biologics specializes in the development and manufacturing of therapeutic proteins, plasmid DNA, viral vectors, and genetically engineered cells for the biopharmaceutical industry. The company provides end-to-end solutions, assisting clients from the initial development stages to full-scale production. Their services are particularly focused on fast-tracking projects for orphan drugs and rare diseases, which often require quicker timelines. AGC Biologics operates a network of advanced facilities across the U.S., Europe, and Asia, all adhering to strict quality regulations known as current Good Manufacturing Practices (cGMP). What sets AGC Biologics apart from competitors is its commitment to continuous innovation and its recent expansion to enhance capabilities in cell and gene therapy. The company's goal is to support biopharmaceutical companies in bringing new treatments to market efficiently and effectively.